Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer

Figure 4

Kaplan-Meier survival analysis of 14-3-3σ expression in subsets of gastric cancer patients with stage III and IV (log-rank test). (A) Probability of overall survival and (B) progression-free survival of patients with stage III gastric cancer in the testing set: low expression, n = 17; high expression, n = 26; (C) Probability of overall survival and (D) progression-free survival of stage IV patients with gastric cancer in the testing set: low expression, n = 5; high expression, n = 11. (E) Probability of overall survival and (F) progression-free survival of patients with stage III gastric cancer in the overall patients: low expression, n = 22; high expression, n = 55; (G) Probability of overall survival and (H) progression-free survival of stage IV patients with gastric cancer in the overall patients: low expression, n = 9; high expression, n = 21.

Back to article page